University of Maryland Medical Center infectious diseases expert available to offer insight on the latest COVID-19 subvariant JN.1
University of Maryland Medical Center
The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women. Two breast cancer experts at the University of Maryland Greenebaum Cancer Center are available to comment on the new guideline.